HCC incidence after hepatitis C cure among patients with advanced fibrosis or cirrhosis: A meta‐analysis
出版年份 2022 全文链接
标题
HCC incidence after hepatitis C cure among patients with advanced fibrosis or cirrhosis: A meta‐analysis
作者
关键词
-
出版物
HEPATOLOGY
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2022-01-15
DOI
10.1002/hep.32341
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- We need stronger evidence for (or against) hepatocellular carcinoma surveillance
- (2021) Peter Jepsen et al. JOURNAL OF HEPATOLOGY
- Impact of direct‐acting antiviral regimens on mortality and morbidity outcomes in patients with chronic hepatitis c: Systematic review and meta‐analysis
- (2021) Yeva Sahakyan et al. JOURNAL OF VIRAL HEPATITIS
- Hepatitis C virus eradication decreases the risks of liver cirrhosis and cirrhosis‐related complications (T‐COACH)
- (2021) Wei‐Fan Hsu et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Comparison of the Prognosis of Decompensated Cirrhosis in Patients with and Without Eradication of Hepatitis C Virus
- (2021) Takashi Kumada et al. Infectious Diseases and Therapy
- Kinetics of emergence of liver complications in HCV-infected patients and advanced fibrosis, with and without HIV-coinfection, after SVR
- (2021) Anaïs Corma-Gómez et al. AIDS
- Hepatocellular carcinoma risk in hepatitis C stage‐3 fibrosis after sustained virological response with direct‐acting antivirals
- (2021) María Sánchez‐Azofra et al. LIVER INTERNATIONAL
- Risk Factors for Liver Decompensation and HCC in HCV-Cirrhotic Patients after DAAs: A Multicenter Prospective Study
- (2021) Filomena Morisco et al. Cancers
- Incidence of HCC in chronic hepatitis C patients with advanced hepatic fibrosis who achieved SVR following DAAs: A prospective study
- (2020) Gamal Shiha et al. JOURNAL OF VIRAL HEPATITIS
- The impact of SVR from direct‐acting antiviral‐ and interferon‐based treatments for HCV on hepatocellular carcinoma risk
- (2020) Naveed Z. Janjua et al. JOURNAL OF VIRAL HEPATITIS
- Association between steatohepatitis biomarkers and hepatocellular carcinoma after hepatitis C elimination
- (2020) Eiichi Ogawa et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Hepatic fat ‐ genetic risk score predicts hepatocellular carcinoma in HCV cirrhotic patients treated with DAAs
- (2020) Elisabetta Degasperi et al. HEPATOLOGY
- aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis
- (2020) Rong Fan et al. JOURNAL OF HEPATOLOGY
- Hepatocellular carcinoma surveillance after hepatitis C virus eradication: Is liver stiffness measurement more useful than laboratory fibrosis markers?
- (2020) Ekaterina Nabatchikova et al. JOURNAL OF HEPATOLOGY
- Personalized surveillance for hepatocellular carcinoma in cirrhosis – using machine learning adapted to HCV status
- (2020) Etienne Audureau et al. JOURNAL OF HEPATOLOGY
- Suboptimal accuracy of GES score to stratify Post‐SVR HCC risk in a single center cohort of European cirrhotics infected with any HCV genotype
- (2020) Irene Bergna et al. LIVER INTERNATIONAL
- GES: A validated simple score to predict risk of HCC in patients with HCV‐GT4 associated advanced liver fibrosis after oral antivirals
- (2020) Gamal Shiha et al. LIVER INTERNATIONAL
- HCC risk post-SVR with DAAs in East Asians: findings from the REAL-C cohort
- (2020) Yasuhito Tanaka et al. Hepatology International
- Factors associated with hepatocellular carcinoma occurrence after HCV eradication in patients without cirrhosis or with compensated cirrhosis
- (2020) Kazumichi Abe et al. PLoS One
- Incidence and risk factors of hepatocellular carcinoma in patients with hepatitis C in China and the United States
- (2020) Ming Yang et al. Scientific Reports
- HCC surveillance after SVR in patients with F3/F4 fibrosis
- (2020) George N. Ioannou JOURNAL OF HEPATOLOGY
- Time association between hepatitis C therapy and hepatocellular carcinoma emergence in cirrhosis: Relevance of non-characterized nodules
- (2019) Zoe Mariño et al. JOURNAL OF HEPATOLOGY
- Increased Risk for Hepatocellular Carcinoma Persists Up to 10 Years After HCV Eradication in Patients with Baseline Cirrhosis or High FIB-4 Scores
- (2019) George N. Ioannou et al. GASTROENTEROLOGY
- Long-term risk of hepatocellular carcinoma in HCV patients treated with direct acting antiviral agents
- (2019) Fasiha Kanwal et al. HEPATOLOGY
- The dynamic effect of direct‐acting antiviral treatments on the risk of hepatocellular carcinoma in patients with cirrhosis and chronic hepatitis C
- (2019) Clovis Lusivika‐Nzinga et al. JOURNAL OF VIRAL HEPATITIS
- Hepatitis C
- (2019) C Wendy Spearman et al. LANCET
- Letter: a 5-year long-term follow-up study after DAA treatment confirms a reduced HCC risk in a central European cohort of HCV patients with liver cirrhosis
- (2019) Friederike Ebel et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases–Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection
- (2019) Marc G. Ghany et al. HEPATOLOGY
- Hepatitis C virus eradication with direct‐acting antiviral improves insulin resistance
- (2019) Francesco Paolo Russo et al. JOURNAL OF VIRAL HEPATITIS
- Diagnosis, Staging and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
- (2018) Jorge A. Marrero et al. HEPATOLOGY
- De novo hepatocellular carcinoma in patients with cirrhosis due hepatitis C virus infection after treatment with direct antiviral agents
- (2018) P. Ruiz et al. JOURNAL OF HEPATOLOGY
- In hepatitis C patients with cirrhosis who achieve SVR with treatment, reduction in transient elastography measures does not translate to reduced risk of hepatocellular carcinoma: A prospective cohort study
- (2018) J. Howell et al. JOURNAL OF HEPATOLOGY
- The risk of hepatocellular carcinoma in cirrhotic patients with hepatitis C and sustained viral response: Role of the treatment regimen
- (2018) Hamish Innes et al. JOURNAL OF HEPATOLOGY
- HCV eradication induced by direct-acting antiviral agents reduces the risk of hepatocellular carcinoma
- (2018) George N. Ioannou et al. JOURNAL OF HEPATOLOGY
- EASL Recommendations on Treatment of Hepatitis C 2018
- (2018) Jean-Michel Pawlotsky et al. JOURNAL OF HEPATOLOGY
- Newly diagnosed hepatocellular carcinoma in patients with advanced hepatitis C treated with DAAs: A prospective population study
- (2018) Antonietta Romano et al. JOURNAL OF HEPATOLOGY
- EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2018) Peter R. Galle et al. JOURNAL OF HEPATOLOGY
- Development of models estimating the risk of hepatocellular carcinoma after antiviral treatment for hepatitis C
- (2018) George N. Ioannou et al. JOURNAL OF HEPATOLOGY
- Cost-effectiveness of Hepatocellular Carcinoma Surveillance After a Sustained Virologic Response to Therapy in Patients With HCV Infection and Advanced Fibrosis
- (2018) Hooman Farhang Zangneh et al. Clinical Gastroenterology and Hepatology
- Predictors of hepatocellular carcinoma in HCV cirrhotic patients treated with direct acting antivirals
- (2018) Ana Lleo et al. DIGESTIVE AND LIVER DISEASE
- Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: A systematic review, meta-analyses, and meta-regression
- (2017) Reem Waziry et al. JOURNAL OF HEPATOLOGY
- High Post-treatment α-Fetoprotein Levels and Aspartate Aminotransferase-to-Platelet Ratio Index Predict Hepatocellular Carcinoma in Hepatitis C Virus Decompensated Cirrhotic Patients with Sustained Virological Response After Antiviral Therapy
- (2017) Fanpu Ji et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Follow-up of sustained virological responders with hepatitis C and advanced liver disease after interferon/ribavirin-free treatment
- (2017) Karin Kozbial et al. LIVER INTERNATIONAL
- Diabetes and Cirrhosis Are Risk Factors for Hepatocellular Carcinoma After Successful Treatment of Chronic Hepatitis C
- (2016) Magnus Hedenstierna et al. CLINICAL INFECTIOUS DISEASES
- Effects of Eradicating Hepatitis C Virus Infection in Patients With Cirrhosis Differ With Stage of Portal Hypertension
- (2016) Vito Di Marco et al. GASTROENTEROLOGY
- Treatment Response and Long-Term Outcome of Peginterferon α and Ribavirin Therapy in Korean Patients with Chronic Hepatitis C
- (2016) Chang Ho Jung et al. Gut and Liver
- High incidence of hepatocellular carcinoma following successful interferon-free antiviral therapy for hepatitis C associated cirrhosis
- (2016) Helder Cardoso et al. JOURNAL OF HEPATOLOGY
- Direct antiviral agent treatment of chronic hepatitis C results in rapid regression of transient elastography and fibrosis markers fibrosis-4 score and aspartate aminotransferase-platelet ratio index
- (2016) Jacqueline A. Bachofner et al. LIVER INTERNATIONAL
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2013) David Moher ANNALS OF INTERNAL MEDICINE
- Eradication of Hepatitis C Virus Infection and the Development of Hepatocellular Carcinoma
- (2013) Rebecca L. Morgan et al. ANNALS OF INTERNAL MEDICINE
- A Risk for Hepatocellular Carcinoma Persists Long-term After Sustained Virologic Response in Patients With Hepatitis C–Associated Liver Cirrhosis
- (2013) Soo Aleman et al. CLINICAL INFECTIOUS DISEASES
- Benefits From Sustained Virologic Response to Pegylated Interferon Plus Ribavirin in HIV/Hepatitis C Virus–Coinfected Patients With Compensated Cirrhosis
- (2013) José A. Mira et al. CLINICAL INFECTIOUS DISEASES
- Association Between Sustained Virological Response and All-Cause Mortality Among Patients With Chronic Hepatitis C and Advanced Hepatic Fibrosis
- (2013) Adriaan J. van der Meer et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Histopathology of type C liver disease for determining hepatocellular carcinoma risk factors
- (2013) Hiroshi Matsumura WORLD JOURNAL OF GASTROENTEROLOGY
- Effect of sustained virologic response on the incidence of hepatocellular carcinoma in patients with HCV cirrhosis
- (2012) Nelson Cheinquer et al. Brazilian Journal of Infectious Diseases
- A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis
- (2012) Roberta D'Ambrosio et al. HEPATOLOGY
- The course of esophageal varices in patients with hepatitis C cirrhosis responding to interferon/ribavirin therapy
- (2011) Roberta D’Ambrosio et al. ANTIVIRAL THERAPY
- Eradication of Hepatitis C Virus Reduces the Risk of Hepatocellular Carcinoma in Patients with Compensated Cirrhosis
- (2011) José Velosa et al. DIGESTIVE DISEASES AND SCIENCES
- Long-Term Outcome After Antiviral Therapy of Patients With Hepatitis C Virus Infection and Decompensated Cirrhosis
- (2010) Angelo Iacobellis et al. Clinical Gastroenterology and Hepatology
- Outcome of sustained virological responders with histologically advanced chronic hepatitis C
- (2010) Timothy R. Morgan et al. HEPATOLOGY
- Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: Incidence and survival in hepatitis C patients with advanced fibrosis
- (2010) Ana-Carolina Cardoso et al. JOURNAL OF HEPATOLOGY
- Antiviral Therapy Reduces Risk of Hepatocellular Carcinoma in Patients With Hepatitis C Virus–Related Cirrhosis
- (2009) Ashwani K. Singal et al. Clinical Gastroenterology and Hepatology
- Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: A 5-year follow-up of 150 patients
- (2008) Sarah L. George et al. HEPATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now